{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06245499",
            "orgStudyIdInfo": {
                "id": "FY23_Demo2_Torke"
            },
            "secondaryIdInfos": [
                {
                    "id": "20249",
                    "type": "OTHER",
                    "domain": "Indiana University Institutional Review Board"
                },
                {
                    "id": "U54AG063546",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/U54AG063546"
                }
            ],
            "organization": {
                "fullName": "Indiana University",
                "class": "OTHER"
            },
            "briefTitle": "Aging Brain Care Virtual Program",
            "officialTitle": "The Aging Brain Care Virtual Program",
            "acronym": "ABCV",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "aging-brain-care-virtual-program"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-11-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-30",
            "studyFirstSubmitQcDate": "2024-01-30",
            "studyFirstPostDateStruct": {
                "date": "2024-02-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-27",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Alexia M. Torke",
                "investigatorTitle": "Professor of Medicine",
                "investigatorAffiliation": "Indiana University"
            },
            "leadSponsor": {
                "name": "Indiana University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Aging (NIA)",
                    "class": "NIH"
                },
                {
                    "name": "Regenstrief Institute, Inc.",
                    "class": "OTHER"
                },
                {
                    "name": "Indiana University Health",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning."
        },
        "conditionsModule": {
            "conditions": [
                "Dementia",
                "Alzheimer Disease"
            ],
            "keywords": [
                "Telehealth",
                "Virtual intervention",
                "Aging brain care"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 860,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intervention",
                    "type": "EXPERIMENTAL",
                    "description": "Care Partners in the intervention group will be approached and offered care coordination through the Aging Brain Care Virtual program",
                    "interventionNames": [
                        "Behavioral: Aging Brain Care Virtual Program"
                    ]
                },
                {
                    "label": "Control",
                    "type": "NO_INTERVENTION",
                    "description": "Care partners in the control group will not be approached, but outcomes data will be collected from the EMR for comparison with the intervention group."
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Aging Brain Care Virtual Program",
                    "description": "The program involves a virtual intervention to be delivered by RN or SW care coordinators over one year. Every care partner will receive monthly virtual visits during the first 3 months and then quarterly or more depending on assessed need. The intervention relies on a tailored approach in which patient and caregiver needs are identified during visits using validated assessment tools and addressed with standardized protocols. Protocols include management of behavioral/psychological symptoms of dementia, caregiver stress, medication management, comorbidity management and advance care planning.",
                    "armGroupLabels": [
                        "Intervention"
                    ],
                    "otherNames": [
                        "ABCV"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Emergency Department Utilization",
                    "description": "Total count of emergency department encounters per patient",
                    "timeFrame": "During the 12 months of intervention"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "New prescriptions for antipsychotic medications",
                    "description": "Total count of new prescriptions for antipsychotic medications",
                    "timeFrame": "During the 12 months of intervention"
                },
                {
                    "measure": "New prescriptions for benzodiazepine medications",
                    "description": "Total count of new prescriptions for benzodiazepine medications",
                    "timeFrame": "During the 12 months of intervention"
                },
                {
                    "measure": "Anticholinergic Cognitive Burden Scale score",
                    "description": "Total score rating the anticholinergic burden of medications the patient is taking There are 88 medications on the Anticholinergic Cognitive Burden Scale.\n\nPossible anticholinergics include those listed with a score of 1; Definite anticholinergics include those listed with a score of 2 or 3.\n\nThe overall ACB score is calculated by adding the score for each possible or definite anticholinergic medication that the patient is taking.\n\nAn ACB Scale score can be as low as 0. The vast majority of patients have an ACB score at or below 4. Scores of 1 are low, 2 are moderate and anything above 3 is considered high. There is no published max score on the ACB scale, however, scores above 4 are somewhat uncommon. The top score could be as high as 264 (88x3)\n\nA higher ACB score indicates higher cognitive burden. Higher scores indicate worse outcomes.",
                    "timeFrame": "Before and 12 months after initial intervention"
                },
                {
                    "measure": "Acceptability of the intervention score",
                    "description": "Acceptability of Intervention Measure (AIM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality.",
                    "timeFrame": "Up to 6 months after the 12 month intervention period"
                },
                {
                    "measure": "Feasibility of the intervention score",
                    "description": "Feasibility of Intervention Measure (FIM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality.",
                    "timeFrame": "Up to 6 months after the 12 month intervention period"
                },
                {
                    "measure": "Appropriateness of the intervention score",
                    "description": "Intervention Appropriateness Measure (IAM) Scores range from 4 to 20. Cut-off scores for interpretation are not yet available however higher scores indicate superior psychometric quality.",
                    "timeFrame": "Up to 6 months after the 12 month intervention period"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Patient Inclusion Criteria:\n\n* 65 and older,\n* active primary care patient (visit in past 14 months),\n* diagnosis of Alzheimer's disease and related dementias (ADRD) based on ICD criteria in primary care problems list.\n\nPatient Exclusion Criteria:\n\n* enrolled in hospice at the study start (study screening)or\n* living in a long term care nursing facility.\n\nCare Partners Inclusion Criteria:\n\n* 18 and older,\n* able to access a phone or computer for intervention delivery in English, and\n* identified in the EMR as the emergency contact or as the primary care partner.\n\nCare Partners Exclusion Criteria:\n\n- Individuals who decline to participate in the ABCV intervention",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Emily S Burke, BA",
                    "role": "CONTACT",
                    "phone": "317-274-9047",
                    "email": "esburke@regenstrief.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Alexia M Torke, MD, MS",
                    "affiliation": "Regenstrief Institute, Inc.",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Regenstrief Institute, Inc.",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Emily S Burke, BA",
                            "role": "CONTACT",
                            "phone": "317-274-9047",
                            "email": "esburke@regenstrief.org"
                        },
                        {
                            "name": "Alexia M Torke, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000544",
                    "term": "Alzheimer Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003704",
                    "term": "Dementia"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000024801",
                    "term": "Tauopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000019965",
                    "term": "Neurocognitive Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3885",
                    "name": "Alzheimer Disease",
                    "asFound": "Alzheimer's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23002",
                    "name": "Tauopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21836",
                    "name": "Neurocognitive Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T2192",
                    "name": "Familial Alzheimer Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}